Laura Haigh
Overview
Explore the profile of Laura Haigh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Karsdal M, Hallsworth K, Scragg J, Leeming D, Villesen I, Avery L, et al.
Hepatol Commun
. 2023 Sep;
7(10).
PMID: 37756043
Background: NAFLD is associated with activation of fibroblasts and hepatic fibrosis. Substantial patient heterogeneity exists, so it remains challenging to risk-stratify patients. We hypothesized that the amount of fibroblast activity,...
2.
Haigh L, Kirk C, El Gendy K, Gallacher J, Errington L, Mathers J, et al.
Clin Nutr
. 2022 Aug;
41(9):1913-1931.
PMID: 35947894
Background & Aims: Lifestyle interventions that focus on reduced energy intake and improved dietary pattern are the mainstay of non-alcoholic fatty liver disease (NAFLD) management. However, it remains unclear which...
3.
Neilson L, Macdougall L, Lee P, Hardy T, Beaton D, Chandrapalan S, et al.
Frontline Gastroenterol
. 2021 Dec;
12(7):578-585.
PMID: 34917315
Background: Non-alcoholic fatty liver disease (NAFLD) is common and is associated with liver-related and cardiovascular-related morbidity. Our aims were: (1) to review the current management of patients with NAFLD attending...
4.
Kirk C, Haigh L, Thompson N, Pearce M, Jones D, Mathers J
Clin Nutr
. 2021 Dec;
41(1):80-90.
PMID: 34864457
Background: Home parenteral nutrition (HPN) is a life-sustaining therapy for individuals with intestinal failure in a community setting. It refers to the intravenous infusion of macronutrients, micronutrients, fluids and electrolytes....
5.
Scragg J, Hallsworth K, Taylor G, Cassidy S, Haigh L, Boyle M, et al.
BMJ Open Gastroenterol
. 2021 Jul;
8(1).
PMID: 34326098
Objective: Clinical guidelines recommend weight loss to manage non-alcoholic fatty liver disease (NAFLD). However, the majority of patients find weight loss a significant challenge. We identified factors associated with engagement...
6.
Hallsworth K, McPherson S, Anstee Q, Flynn D, Haigh L, Avery L
J Med Internet Res
. 2021 Jan;
23(1):e20491.
PMID: 33448929
Background: Nonalcoholic fatty liver disease (NAFLD) is linked to excessive calorie consumption, physical inactivity, and being overweight. Patients with NAFLD can halt or decelerate progression and potentially reverse their condition...
7.
Scragg J, Avery L, Cassidy S, Taylor G, Haigh L, Boyle M, et al.
Clin Transl Gastroenterol
. 2020 Oct;
11(9):e00231.
PMID: 33094956
Introduction: Nonalcoholic fatty liver disease (NAFLD) is the most common liver condition worldwide. A weight loss goal of ≥10% is the recommended treatment for NAFLD; however, only a minority of...
8.
Haigh L, Bremner S, Houghton D, Henderson E, Avery L, Hardy T, et al.
Clin Gastroenterol Hepatol
. 2018 Nov;
17(7):1364-1371.e3.
PMID: 30391437
Background & Aims: Dietary interventions for weight loss are effective therapies for nonalcoholic fatty liver disease (NAFLD). The Mediterranean diet might benefit these patients, but it is not followed consistently...
9.
Haigh L, Thompson K
Animals (Basel)
. 2015 Oct;
5(3):576-91.
PMID: 26479375
Equestrian activities pose significant head injury risks to participants. Yet, helmet use is not mandatory in Australia outside of selected competitions. Awareness of technical countermeasures and the dangers of equestrian...